{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:27:04Z","timestamp":1788352024136,"version":"build-2803163510"},"reference-count":43,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,12,20]]},"DOI":"10.3233\/jad-160740","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T11:43:30Z","timestamp":1479815010000},"page":"1471-1480","source":"Crossref","is-referenced-by-count":43,"title":["Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and A\u03b242 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer\u2019s Disease with Emphasis on Atypical Disease Variants"],"prefix":"10.1177","volume":"55","author":[{"given":"Samir","family":"Abu Rumeileh","sequence":"first","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lattanzio","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Stanzani Maserati","sequence":"additional","affiliation":[{"name":"IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Rizzi","sequence":"additional","affiliation":[{"name":"Department of Neurology, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Capellari","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"},{"name":"IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"},{"name":"IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160740_ref1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160740_ref2","first-page":"20","article-title":"Molecular pathology, classification, and diagnosis of sporadic human prion disease variants","volume":"50","author":"Parchi","year":"2012","journal-title":"Folia Neuropathol"},{"key":"10.3233\/JAD-160740_ref3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000102017","article-title":"Fast cognitive decline at the time of dementia diagnosis: A major prognostic factor for survival in the community","volume":"23","author":"Carcaillon","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-160740_ref4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00415-004-0480-6","article-title":"Rapidly progressive Alzheimer\u2019s disease mimicking Creutzfeldt-Jakob disease","volume":"251","author":"Reinwald","year":"2004","journal-title":"J Neurol"},{"key":"10.3233\/JAD-160740_ref5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-2012-120007","article-title":"Rapidly progressive Alzheimer\u2019s disease: A multicenter update","volume":"30","author":"Schmidt","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160740_ref6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","article-title":"Rapidly progressive Alzheimer disease","volume":"68","author":"Schmidt","year":"2011","journal-title":"Arch Neurol"},{"issue":"Pt 10","key":"10.3233\/JAD-160740_ref7","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-160740_ref8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrneurol.2012.253","article-title":"Prion disease: Diagnostic value of cerebrospinal fluid markers","volume":"9","author":"Parchi","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-160740_ref9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160740_ref10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160740_ref11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.WNL.0000078890.89473.ED","article-title":"14-3-3 protein in the CSF of patients with rapidly progressive dementia","volume":"61","author":"Huang","year":"2003","journal-title":"Neurology"},{"key":"10.3233\/JAD-160740_ref12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ageing\/afn094","article-title":"Rapidly progressive Alzheimer\u2019s disease and elevated 14-3-3 proteins in cerebrospinal fluid","volume":"37","author":"Jayaratnam","year":"2008","journal-title":"Age Ageing"},{"key":"10.3233\/JAD-160740_ref13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1212\/WNL.0b013e3181bd8271","article-title":"CSF biomarkers predict rate of cognitive decline in Alzheimer disease","volume":"73","author":"Kester","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-160740_ref14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/WAD.0b013e3181d712d9","article-title":"Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease?","volume":"24","author":"Koric","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-160740_ref15","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1532-5415.2010.03051.x","article-title":"Atypical case of Alzheimer\u2019s disease mimicking Creutzfeldt-Jakob disease: Interest of cerebrospinal fluid biomarkers in the differential diagnosis","volume":"58","author":"Mahmoudi","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-160740_ref16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archneurol.2009.55","article-title":"Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type","volume":"66","author":"Snider","year":"2009","journal-title":"Arch Neurol"},{"issue":"Pt 10","key":"10.3233\/JAD-160740_ref17","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","article-title":"Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: A longitudinal multicentre study over 10 years","volume":"135","author":"Stoeck","year":"2012","journal-title":"Brain"},{"key":"10.3233\/JAD-160740_ref18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.0b013e3181dd4dd8","article-title":"CSF biomarkers predict a more malignant outcome in Alzheimer disease","volume":"74","author":"Wallin","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-160740_ref19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.WNL.0000135153.96325.3B","article-title":"Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease","volume":"63","author":"Castellani","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-160740_ref20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"67","author":"Sanchez-Juan","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-160740_ref21","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.3390\/ijms12096281","article-title":"Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease","volume":"12","author":"Zanusso","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-160740_ref22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3233\/JAD-1999-1606","article-title":"Decreased levels of amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients","volume":"1","author":"Van Everbroeck","year":"1999","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160740_ref23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.54.5.1099","article-title":"Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"54","author":"Otto","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-160740_ref24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","article-title":"Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: A discrimination from Alzheimer\u2019s disease?","volume":"71","author":"Kapaki","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-160740_ref25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ana.10661","article-title":"Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"54","author":"Wiltfang","year":"2003","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-160740_ref26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00702-010-0543-z","article-title":"Different CSF \u03b2-amyloid processing in Alzheimer\u2019s and Creutzfeldt-Jakob disease","volume":"118","author":"Mollenhauer","year":"2011","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-160740_ref27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-2010-101527","article-title":"Amyloid-\u03b2 1-42 levels are modified by apolipoprotein E \u025b4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer\u2019s disease","volume":"23","author":"Varges","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160740_ref28","first-page":"1147","article-title":"Diagnostic value of 14-3-3beta immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease","volume":"16","author":"Blennow","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.3233\/JAD-160740_ref29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaneurol.2014.4068","article-title":"Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease","volume":"72","author":"Dorey","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-160740_ref30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: Results from the Swedish Mortality Registry","volume":"71","author":"Skillb\u00e4ck","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-160740_ref31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160740_ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160740_ref33","doi-asserted-by":"crossref","first-page":"e36333","DOI":"10.1371\/journal.pone.0036333","article-title":"Human prion diseases in the Netherlands (1998-2009): Clinical, genetic and molecular aspects","volume":"7","author":"Jansen","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160740_ref34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","article-title":"Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: An inter-rater study among surveillance centres in Europe and USA","volume":"124","author":"Parchi","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160740_ref35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1750-3639.2008.00187.x","article-title":"Inter-laboratory assessment of PrPSc typing in Creutzfeldt-Jakob disease: A western blot study within the NeuroPrion Consortium","volume":"19","author":"Parchi","year":"2009","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-160740_ref36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3233\/JAD-150668","article-title":"Revisiting the Heidenhain variant of Creutzfeldt-Jakob disease: Evidence for prion type variability influencing clinical course and laboratory findings","volume":"50","author":"Baiardi","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160740_ref37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/pri.26416","article-title":"PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2","volume":"7","author":"Llorens","year":"2013","journal-title":"Prion"},{"key":"10.3233\/JAD-160740_ref38","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.neurobiolaging.2013.11.010","article-title":"Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases","volume":"35","author":"Schmitz","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160740_ref39","doi-asserted-by":"crossref","first-page":"e36159","DOI":"10.1371\/journal.pone.0036159","article-title":"Altered prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease","volume":"7","author":"Torres","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-160740_ref40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-2009-1110","article-title":"Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders","volume":"17","author":"Meyne","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160740_ref41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fneur.2015.00138","article-title":"Cerebrospinal fluid P-Tau181P: Biomarker for improved differential dementia diagnosis","volume":"6","author":"Struyfs","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-160740_ref42","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archneurol.2009.224","article-title":"Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype","volume":"66","author":"Ghoshal","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160740_ref43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Laur\u00e9n","year":"2009","journal-title":"Nature"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:32Z","timestamp":1777370672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160740"}},"subtitle":[],"editor":[{"given":"Katharina","family":"Stoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":43,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-160740","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}